Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
Deepak Yadav, Consultant and Assistant Professor of Neurology at Amrita Hospital, shared on LinkedIn:
”Stroke Care Just Changed: What 2025 Evidence Tells Us (And Why It Matters)
Stroke medicine is moving fast — and 2025 quietly rewrote several ‘assumed truths.’
The European Stroke Organisation (ESO) Annual Stroke Evidence Update 2025 synthesised the most practice-changing trials across acute care, prevention, rehab, cognition, and systems of care
Acute Ischemic Stroke: Less Is More
Endovascular thrombectomy (EVT)
NO routine benefit for MeVO strokes
Medical therapy (including IV thrombolysis when eligible) remains the backbone
Bigger is not always better intervention
Tenecteplase (TNK)
TNK before thrombectomy improves 90-day functional outcomes
Higher early recanalisation vs alteplase
TNK is now strongly reinforced as bridging therapy
Late-window thrombolysis (4.5–24 h)
Can help highly selected patients using advanced imaging
Tissue > time, but selection is everything
Intracerebral Haemorrhage (ICH): TIME equals BRAIN
Blood pressure control
Early, intensive BP lowering (<140 mmHg) is SAFE
Best outcomes when started within 3 hours. Delay here = lost recovery
Post-ICH prevention
Low-dose polypill strategy achieved SBP ≈127 mmHg
Reduced recurrent stroke without added harm
Simple combinations beat therapeutic inertia
Secondary Prevention: Old Dogmas Fall
Atrial fibrillation
Early DOAC initiation (≤4 days) ↓ recurrent stroke
Adding antiplatelet therapy? More bleeding, no benefit
ESUS
Anticoagulation still does NOT beat aspirin, Precision is better than empiricism
Factor XIa inhibition (Asundexian)
Infrequent ischaemic stroke without more bleeding
Works in non-cardioembolic stroke / high-risk TIA
A glimpse of safer antithrombotic future
Cognition and Life After Stroke
Post-stroke dementia
Risk continues for YEARS
Metabolic syndrome equals major modifiable driver
Acute reperfusion- lower dementia risk by ~65%
What helps cognition?
- Computerised cognitive training
- Brain stimulation
- Cardiorespiratory exercise
Stroke care does not equal discharge care
Systems of Care: Organisation saves Neurons
- Mobile Stroke Units
Improve outcomes
Cost-effective in high-volume systems
- Workflow optimisation
Behaviour-change packages – lower door-to-puncture time
Better 90-day outcomes
Process design is a treatment
What Everyone Should Know
- EVT – not for all vessel occlusions
- Tenecteplase is gaining ground
- BP control after ICH is urgent, not optional
- Early anticoagulation in AF is safer than we thought
- Stroke recurrence risk remains high for years
- Cognition and rehabilitation are not ‘extras’
- Systems and workflows save as many lives as drugs
Final Thought
Stroke care is no longer about doing more — It’s about doing the right thing, faster, for the right patient.
Source: European Stroke Organisation – Annual Stroke Evidence Update 2025 (European Stroke Journal, 2026)”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon